Skip to main content

Breadcrumb

  1. Home

QTX3034 in Patients With KRAS G12D Mutation

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about QTX3034 in Patients With KRAS G12D Mutation

Long-Term Outcomes of Children With Congenital CMV in New York State

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about Long-Term Outcomes of Children With Congenital CMV in New York State

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCC

Optimal Stent Duration After Ureteroscopy

Submitted by Anonymous (not verified) on Thu, 07/17/2025 - 17:36
  • Read more about Optimal Stent Duration After Ureteroscopy

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • …
  • Next page Next
  • Last page Last
Subscribe to